JAGX (STOCKS)
Jaguar Health, Inc.
$2.430000
-0.260000 (-9.67%)
Prev close: $2.690000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Lisa A. Conte
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1.47M
- Employees
- 49
- P/E (TTM)
- —
- P/B (TTM)
- -0.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-13.60 | $-2.08 | -11.5192 | -553.59% |
|
Sep 2025 (Q3)
|
$-219.80 | $-181.36 | -38.4440 | -21.20% |
|
Jun 2025 (Q2)
|
$-359.10 | $-254.54 | -104.5590 | -41.08% |
|
Mar 2025 (Q1)
|
$-584.50 | $-642.60 | +58.1000 | +9.04% |
Financial Statements
| Revenues | $29.57M |
| Benefits Costs and Expenses | $64.25M |
| Cost Of Revenue | $4.42M |
| Costs And Expenses | $55.87M |
| Gross Profit | $25.15M |
| Operating Expenses | $51.46M |
| Research and Development | $25.16M |
| Other Operating Expenses | $26.29M |
| Operating Income/Loss | -$26.31M |
| Income/Loss Before Equity Method Investments | -$34.54M |
| Income/Loss From Continuing Operations After Tax | -$34.68M |
| Income/Loss From Continuing Operations Before Tax | -$34.68M |
| Income/Loss From Equity Method Investments | -$138.00K |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $822.00K |
| Net Income/Loss | -$34.68M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$557.00K |
| Net Income/Loss Attributable To Parent | -$50.13M |
| Net Income/Loss Available To Common Stockholders, Basic | -$50.13M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$30.50 |
| Diluted Earnings Per Share | -$30.50 |
| Basic Average Shares | 4,032,707 |
| Diluted Average Shares | 4,032,707 |
| Assets | $37.43M |
| Current Assets | $20.21M |
| Inventory | $7.82M |
| Other Current Assets | $12.39M |
| Noncurrent Assets | $17.22M |
| Fixed Assets | $423.00K |
| Intangible Assets | $15.55M |
| Other Non-current Assets | $1.25M |
| Liabilities | $53.19M |
| Current Liabilities | $40.69M |
| Accounts Payable | $4.96M |
| Other Current Liabilities | $35.73M |
| Noncurrent Liabilities | $12.50M |
| Equity | -$15.75M |
| Equity Attributable To Noncontrolling Interest | -$1.57M |
| Equity Attributable To Parent | -$14.18M |
| Liabilities And Equity | $37.43M |
| Net Cash Flow From Operating Activities | -$7.54M |
| Net Cash Flow From Operating Activities, Continuing | -$7.54M |
| Net Cash Flow From Investing Activities | -$4.60M |
| Net Cash Flow From Investing Activities, Continuing | -$4.60M |
| Net Cash Flow From Financing Activities | $12.09M |
| Net Cash Flow From Financing Activities, Continuing | $12.09M |
| Net Cash Flow | -$57.00K |
| Net Cash Flow, Continuing | -$57.00K |
| Comprehensive Income/Loss | -$51.15M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$622.00K |
| Comprehensive Income/Loss Attributable To Parent | -$50.67M |
| Other Comprehensive Income/Loss | -$607.00K |